Obesity Clinical Trial
Official title:
Effect of Exercise and Weight Loss on Cardiovascular Health
The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity [moderate physical activity (MOD-PA) = 150 min/wk] versus a higher dose of physical activity [high physical activity (HIGH-PA) = 250 min/wk] in the context of a comprehensive behavioral weight loss program that a includes a reduction in energy intake measures of cardiovascular function using cardiac MRI and biomarkers of vascular disease risk. Each of these exercise doses will be compared independently to a Diet Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for a period of 12 months. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume, aortic distensibility), inflammatory markers (CRP and TNFα) and selected adipocytokines (adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids, glucose, insulin, blood pressure). Additional secondary analyses will allow for examination of the effects of physical activity independent of weight change on the primary and secondary outcomes.
Current estimates indicate that in excess of 65 percent of adults in the United States are
overweight (BMI >25.0 kg/m2) with at least 30 percent of adults classified as obese (BMI >30
kg/m2). Overweight and obesity have been linked to numerous chronic conditions including
cardiovascular disease. The application of cardiac MRI (CMRI) allows for direct measurement
of the cardiac structure, and left ventricular mass (LVM) assessed by CMRI has been shown to
be predictive of cardiovascular disease. Recent studies have shown that LVM is decreased with
weight loss; however, there is a lack of information on the added benefit of physical
activity to weight loss on these direct measures of cardiovascular structure and function.
Thus, consistent with PA-09-243, this study will examine the effect of two recommended doses
of physical activity combined with a dietary intervention on changes in the proposed outcomes
of cardiovascular disease risk in overweight adults.
The primary aim of this study is to examine the effect of the consensus public health
recommended level of physical activity [moderate physical activity (MOD-PA) = 150 min/wk]
versus a higher dose of physical activity [high physical activity (HIGH-PA) = 250 min/wk] in
the context of a comprehensive behavioral weight loss program that a includes a reduction in
energy intake measures of cardiovascular function using cardiac MRI and biomarkers of
vascular disease risk. Each of these exercise doses will be compared independently to a Diet
Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also
compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults
who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for
a period of 12 months. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes
include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume,
aortic distensibility), inflammatory markers (CRP and TNFα) and selected adipocytokines
(adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body
composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids,
glucose, insulin, blood pressure). Additional secondary analyses will allow for examination
of the effects of physical activity independent of weight change on the primary and secondary
outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |